Royal Bank of Canada reissued their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $235.00 target price on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Wells Fargo & […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price trimmed by Chardan Capital from $250.00 to $225.00 in a research report released on Friday, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of a number of other reports. Wells Fargo & Company initiated […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Earns Buy Rating from Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given Buy Rating at Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They currently have a $200.00 price objective on the biopharmaceutical company’s stock. Needham & Company LLC’s price target points to a potential upside of 36.05% from the […]